The Fanconi anemia protein interaction network: Casting a wide net

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 668, Issue 1-2, 2009, Pages 27-41

  Rego, Meghan A ^a   Kolling IV, Frederick W ^a   Howlett, Niall G ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Chromosome instability; DNA repair; Fanconi anemia; Homologous recombination; Translesion DNA synthesis

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BLOOM SYNDROME HELICASE; BRCA1 PROTEIN; BRCA2 PROTEIN; BRG1 PROTEIN; CHECKPOINT KINASE 1; CYCLINE; DNA; DNA POLYMERASE REV1; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA PROTEIN; HISTONE H2AX; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MRE11 PROTEIN; NIBRIN; RAD18 PROTEIN; RAD50 PROTEIN; RAD51 PROTEIN; UBIQUITIN CONJUGATING ENZYME E2;

CHROMOSOMAL INSTABILITY; COMPLEX FORMATION; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FANCONI ANEMIA; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; UBIQUITINATION;

CHROMOSOMAL INSTABILITY; DNA; DNA REPAIR; EPISTASIS, GENETIC; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; MODELS, BIOLOGICAL; RECOMBINATION, GENETIC;

MAMMALIA;

EID: 67650490685     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.11.018     Document Type: Review

References (188)

1. Fornace Jr. A.J., Little J.B., and Weichselbaum R.R. DNA repair in a Fanconi's anemia fibroblast cell strain. Biochim. Biophys. Acta 561 (1979) 99-109
2. Fujiwara Y., and Tatsumi M. Repair of mitomycin C damage to DNA in mammalian cells and its impairment in Fanconi's anemia cells. Biochem. Biophys. Res. Commun. 66 (1975) 592-598
3. Rainbow A.J., and Howes M. Defective repair of ultraviolet- and gamma-ray-damaged DNA in Fanconi's anaemia. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 31 (1977) 191-195
4. Auerbach A.D. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp. Hematol. 21 (1993) 731-733
5. Baumann P., and West S.C. Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem. Sci. 23 (1998) 247-251
6. Haber J.E. Partners and pathways repairing a double-strand break. Trends Genet. 16 (2000) 259-264
7. Sharan S.K., Morimatsu M., Albrecht U., Lim D.S., Regel E., Dinh C., Sands A., Eichele G., Hasty P., and Bradley A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386 (1997) 804-810
8. Lim D.S., and Hasty P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16 (1996) 7133-7143
9. Suzuki A., de la Pompa J.L., Hakem R., Elia A., Yoshida R., Mo R., Nishina H., Chuang T., Wakeham A., Itie A., Koo W., Billia P., Ho A., Fukumoto M., Hui C.C., and Mak T.W. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11 (1997) 1242-1252
10. Mizuta R., LaSalle J.M., Cheng H.L., Shinohara A., Ogawa H., Copeland N., Jenkins N.A., Lalande M., and Alt F.W. RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6927-6932
11. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., and D'Andrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 (2002) 606-609
12. Chen C.F., Chen P.L., Zhong Q., Sharp Z.D., and Lee W.H. Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G(2)/M checkpoint control. J. Biol. Chem. 274 (1999) 32931-32935
13. Chen P.L., Chen C.F., Chen Y., Xiao J., Sharp Z.D., and Lee W.H. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5287-5292
14. Marmorstein L.Y., Ouchi T., and Aaronson S.A. The BRCA2 gene product functionally interacts with p53 and RAD51. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13869-13874
15. Wong A.K., Pero R., Ormonde P.A., Tavtigian S.V., and Bartel P.L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272 (1997) 31941-31944
16. Boulton S.J. Cellular functions of the BRCA tumour-suppressor proteins. Biochem. Soc. Trans. 34 (2006) 633-645
17. Thorslund T., and West S.C. BRCA2: a universal recombinase regulator. Oncogene 26 (2007) 7720-7730
18. Xia B., Sheng Q., Nakanishi K., Ohashi A., Wu J., Christ N., Liu X., Jasin M., Couch F.J., and Livingston D.M. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell 22 (2006) 719-729
19. Godthelp B.C., Wiegant W.W., Waisfisz Q., Medhurst A.L., Arwert F., Joenje H., and Zdzienicka M.Z. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat. Res. 594 (2006) 39-48
20. Reid S., Schindler D., Hanenberg H., Barker K., Hanks S., Kalb R., Neveling K., Kelly P., Seal S., Freund M., Wurm M., Batish S.D., Lach F.P., Yetgin S., Neitzel H., Ariffin H., Tischkowitz M., Mathew C.G., Auerbach A.D., and Rahman N. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat. Genet. 39 (2007) 162-164
21. Xia B., Dorsman J.C., Ameziane N., de Vries Y., Rooimans M.A., Sheng Q., Pals G., Errami A., Gluckman E., Llera J., Wang W., Livingston D.M., Joenje H., and de Winter J.P. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet. 39 (2007) 159-161
22. Digweed M., Rothe S., Demuth I., Scholz R., Schindler D., Stumm M., Grompe M., Jordan A., and Sperling K. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 23 (2002) 1121-1126
23. Ohashi A., Zdzienicka M.Z., Chen J., and Couch F.J. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage. J. Biol. Chem. 280 (2005) 14877-14883
24. Wang X., Andreassen P.R., and D'Andrea A.D. Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in Chromatin. Mol. Cell. Biol. 24 (2004) 5850-5862
25. Offit K., Levran O., Mullaney B., Mah K., Nafa K., Batish S.D., Diotti R., Schneider H., Deffenbaugh A., Scholl T., Proud V.K., Robson M., Norton L., Ellis N., Hanenberg H., and Auerbach A.D. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. J. Natl. Cancer Inst. 95 (2003) 1548-1551
26. Wagner J.E., Tolar J., Levran O., Scholl T., Deffenbaugh A., Satagopan J., Ben-Porat L., Mah K., Batish S.D., Kutler D.I., MacMillan M.L., Hanenberg H., and Auerbach A.D. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood 103 (2004) 3226-3229
27. Reid S., Renwick A., Seal S., Baskcomb L., Barfoot R., Jayatilake H., Pritchard-Jones K., Stratton M.R., Ridolfi-Luthy A., and Rahman N. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour. J. Med. Genet. 42 (2005) 147-151
28. Hirsch B., Shimamura A., Moreau L., Baldinger S., Hag-alshiekh M., Bostrom B., Sencer S., and D'Andrea A.D. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 103 (2004) 2554-2559
29. Zhang H., Tombline G., and Weber B.L. BRCA1, BRCA2, and DNA damage response: collision or collusion?. Cell 92 (1998) 433-436
30. Rajan J.V., Wang M., Marquis S.T., and Chodosh L.A. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13078-13083
31. Scully R., Chen J., Plug A., Xiao Y., Weaver D., Feunteun J., Ashley T., and Livingston D.M. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells. Cell 88 (1997) 265-275
32. Gowen L.C., Johnson B.L., Latour A.M., Sulik K.K., and Koller B.H. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12 (1996) 191-194
33. Hakem R., de la Pompa J.L., Sirard C., Mo R., Woo M., Hakem A., Wakeham A., Potter J., Reitmair A., Billia F., Firpo E., Hui C.C., Roberts J., Rossant J., and Mak T.W. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85 (1996) 1009-1023
34. Ludwig T., Chapman D.L., Papaioannou V.E., and Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11 (1997) 1226-1241
35. Chen J., Silver D.P., Walpita D., Cantor S.B., Gazdar A.F., Tomlinson G., Couch F.J., Weber B.L., Ashley T., Livingston D.M., and Scully R. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2 (1998) 317-328
36. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., and D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262
37. Timmers C., Taniguchi T., Hejna J., Reifsteck C., Lucas L., Bruun D., Thayer M., Cox B., Olson S., D'Andrea A., Moses R., and Grompe M. Positional cloning of a novel Fanconi Anemia gene, FANCD2. Mol. Cell 7 (2001) 241-248
38. Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., and Livingston D.M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90 (1997) 425-435
39. Scully R., Ganesan S., Brown M., De Caprio J.A., Cannistra S.A., Feunteun J., Schnitt S., and Livingston D.M. Location of BRCA1 in human breast and ovarian cancer cells. Science 272 (1996) 123-126
40. Zhong Q., Chen C.F., Li S., Chen Y., Wang C.C., Xiao J., Chen P.L., Sharp Z.D., and Lee W.H. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285 (1999) 747-750
41. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., and D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100 (2002) 2414-2420
42. Folias A., Matkovic M., Bruun D., Reid S., Hejna J., Grompe M., D'Andrea A., and Moses R. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum. Mol. Genet. 11 (2002) 2591-2597
43. Cantor S.B., Bell D.W., Ganesan S., Kass E.M., Drapkin R., Grossman S., Wahrer D.C., Sgroi D.C., Lane W.S., Haber D.A., and Livingston D.M. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105 (2001) 149-160
44. Litman R., Peng M., Jin Z., Zhang F., Zhang J., Powell S., Andreassen P.R., and Cantor S.B. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8 (2005) 255-265
45. Cantor S.B., and Andreassen P.R. Assessing the Link between BACH1 and BRCA1 in the FA Pathway. Cell Cycle 5 (2006) 164-167
46. Peng M., Litman R., Xie J., Sharma S., Brosh Jr. R.M., and Cantor S.B. The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells. EMBO J. 26 (2007) 3238-3249
47. Hashizume R., Fukuda M., Maeda I., Nishikawa H., Oyake D., Yabuki Y., Ogata H., and Ohta T. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276 (2001) 14537-14540
48. Vandenberg C.J., Gergely F., Ong C.Y., Pace P., Mallery D.L., Hiom K., and Patel K.J. BRCA1-independent ubiquitination of FANCD2. Mol. Cell 12 (2003) 247-254
49. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., Hoatlin M.E., Joenje H., and Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35 (2003) 165-170
50. Meetei A.R., Sechi S., Wallisch M., Yang D., Young M.K., Joenje H., Hoatlin M.E., and Wang W. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23 (2003) 3417-3426
51. Moynahan M.E., Chiu J.W., Koller B.H., and Jasin M. Brca1 controls homology-directed DNA repair. Mol. Cell 4 (1999) 511-518
52. Moynahan M.E., Cui T.Y., and Jasin M. Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res. 61 (2001) 4842-4850
53. Moynahan M.E., Pierce A.J., and Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell 7 (2001) 263-272
54. Snouwaert J.N., Gowen L.C., Latour A.M., Mohn A.R., Xiao A., DiBiase L., and Koller B.H. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Oncogene 18 (1999) 7900-7907
55. Hirano S., Yamamoto K., Ishiai M., Yamazoe M., Seki M., Matsushita N., Ohzeki M., Yamashita Y.M., Arakawa H., Buerstedde J.M., Enomoto T., Takeda S., Thompson L.H., and Takata M. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J. 24 (2005) 418-427
56. Nakanishi K., Yang Y.G., Pierce A.J., Taniguchi T., Digweed M., D'Andrea A.D., Wang Z.Q., and Jasin M. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1110-1115
57. Niedzwiedz W., Mosedale G., Johnson M., Ong C.Y., Pace P., and Patel K.J. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15 (2004) 607-620
58. Yamamoto K., Hirano S., Ishiai M., Morishima K., Kitao H., Namikoshi K., Kimura M., Matsushita N., Arakawa H., Buerstedde J.M., Komatsu K., Thompson L.H., and Takata M. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol. Cell. Biol. 25 (2005) 34-43
59. Yamamoto K., Ishiai M., Matsushita N., Arakawa H., Lamerdin J.E., Buerstedde J.M., Tanimoto M., Harada M., Thompson L.H., and Takata M. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol. 23 (2003) 5421-5430
60. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G., Taylor A.M., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., and Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268 (1995) 1749-1753
61. Chun H.H., and Gatti R.A. Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst.) 3 (2004) 1187-1196
62. Taylor A.M., Metcalfe J.A., Thick J., and Mak Y.F. Leukemia and lymphoma in ataxia telangiectasia. Blood 87 (1996) 423-438
63. Kastan M.B., Lim D.S., Kim S.T., and Yang D. ATM-a key determinant of multiple cellular responses to irradiation. Acta Oncol. 40 (2001) 686-688
64. Kitagawa R., and Kastan M.B. The ATM-dependent DNA damage signaling pathway. Cold Spring Harb. Symp. Quant. Biol. 70 (2005) 99-109
65. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., and Elledge S.J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10389-10394
66. Falck J., Mailand N., Syljuasen R.G., Bartek J., and Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410 (2001) 842-847
67. Mailand N., Falck J., Lukas C., Syljuasen R.G., Welcker M., Bartek J., and Lukas J. Rapid destruction of human Cdc25A in response to DNA damage. Science 288 (2000) 1425-1429
68. Djuzenova C., Flentje M., and Plowman P.N. Radiation response in vitro of fibroblasts from a fanconi anemia patient with marked clinical radiosensitivity. Strahlenther Onkol. 180 (2004) 789-797
69. Djuzenova C.S., and Flentje M. Characterization of Fanconi anemia fibroblasts in terms of clonogenic survival and DNA damage assessed by the Comet assay. Med. Sci. Monit. 8 (2002) BR421-430
70. Alter B.P. Radiosensitivity in Fanconi's anemia patients. Radiother. Oncol. 62 (2002) 345-347
71. Marcou Y., D'Andrea A., Jeggo P.A., and Plowman P.N. Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. Radiother. Oncol. 60 (2001) 75-79
72. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.T., Lane W.S., Kastan M.B., and D'Andrea A.D. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109 (2002) 459-472
73. Carney J.P., Maser R.S., Olivares H., Davis E.M., Le Beau M., Yates III J.R., Hays L., Morgan W.F., and Petrini J.H. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93 (1998) 477-486
74. Stewart G.S., Maser R.S., Stankovic T., Bressan D.A., Kaplan M.I., Jaspers N.G., Raams A., Byrd P.J., Petrini J.H., and Taylor A.M. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99 (1999) 577-587
75. Xu B., Kim S., and Kastan M.B. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21 (2001) 3445-3450
76. Matsuura S., Tauchi H., Nakamura A., Kondo N., Sakamoto S., Endo S., Smeets D., Solder B., Belohradsky B.H., Der Kaloustian V.M., Oshimura M., Isomura M., Nakamura Y., and Komatsu K. Positional cloning of the gene for Nijmegen breakage syndrome. Nat. Genet. 19 (1998) 179-181
77. Varon R., Vissinga C., Platzer M., Cerosaletti K.M., Chrzanowska K.H., Saar K., Beckmann G., Seemanova E., Cooper P.R., Nowak N.J., Stumm M., Weemaes C.M., Gatti R.A., Wilson R.K., Digweed M., Rosenthal A., Sperling K., Concannon P., and Reis Nibrin A. A novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93 (1998) 467-476
78. Demuth I., and Digweed M. The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome. Oncogene 26 (2007) 7792-7798
79. Kondratenko I., Paschenko O., Polyakov A., and Bologov A. Nijmegen breakage syndrome. Adv. Exp. Med. Biol. 601 (2007) 61-67
80. Digweed M., and Sperling K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst.) 3 (2004) 1207-1217
81. Lavin M.F. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26 (2007) 7749-7758
82. de Jager M., van Noort J., van Gent D.C., Dekker C., Kanaar R., and Wyman C. Human Rad50/Mre11 is a flexible complex that can tether DNA ends. Mol. Cell 8 (2001) 1129-1135
83. Paull T.T., and Gellert M. The 3′ to 5′ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. Mol. Cell 1 (1998) 969-979
84. Paull T.T., and Gellert M. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev. 13 (1999) 1276-1288
85. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
86. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., and Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22 (2003) 5612-5621
87. Nakanishi K., Taniguchi T., Ranganathan V., New H.V., Moreau L.A., Stotsky M., Mathew C.G., Kastan M.B., Weaver D.T., and D'Andrea A.D. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat. Cell Biol. 4 (2002) 913-920
88. Pichierri P., and Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 23 (2004) 1178-1187
89. Ellis N.A., Groden J., Ye T.Z., Straughen J., Lennon D.J., Ciocci S., Proytcheva M., and German J. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83 (1995) 655-666
90. Ellis N.A., Lennon D.J., Proytcheva M., Alhadeff B., Henderson E.E., and German J. Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells. Am. J. Hum. Genet. 57 (1995) 1019-1027
91. Amor-Gueret M. Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis. Cancer Lett. 236 (2006) 1-12
92. Cheok C.F., Bachrati C.Z., Chan K.L., Ralf C., Wu L., and Hickson I.D. Roles of the Bloom's syndrome helicase in the maintenance of genome stability. Biochem. Soc. Trans. 33 (2005) 1456-1459
93. Kitao S., Shimamoto A., Goto M., Miller R.W., Smithson W.A., Lindor N.M., and Furuichi Y. Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat. Genet. 22 (1999) 82-84
94. Yu C.E., Oshima J., Fu Y.H., Wijsman E.M., Hisama F., Alisch R., Matthews S., Nakura J., Miki T., Ouais S., Martin G.M., Mulligan J., and Schellenberg G.D. Positional cloning of the Werner's syndrome gene. Science 272 (1996) 258-262
95. Mohaghegh P., Karow J.K., Brosh Jr Jr. R.M., Bohr V.A., and Hickson I.D. The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res. 29 (2001) 2843-2849
96. Chaganti R.S., Schonberg S., and German J. A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 71 (1974) 4508-4512
97. Meetei A.R., Levitus M., Xue Y., Medhurst A.L., Zwaan M., Ling C., Rooimans M.A., Bier P., Hoatlin M., Pals G., de Winter J.P., Wang W., and Joenje H. X-linked inheritance of Fanconi anemia complementation group B. Nat. Genet. 36 (2004) 1219-1224
98. Meetei A.R., Medhurst A.L., Ling C., Xue Y., Singh T.R., Bier P., Steltenpool J., Stone S., Dokal I., Mathew C.G., Hoatlin M., Joenje H., de Winter J.P., and Wang W. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37 (2005) 958-963
99. Pichierri P., Franchitto A., and Rosselli F. BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. EMBO J. 23 (2004) 3154-3163
100. Sung P., and Klein H. Mechanism of homologous recombination: mediators and helicases take on regulatory functions. Nat. Rev. Mol. Cell. Biol. 7 (2006) 739-750
101. Wu L. Role of the BLM helicase in replication fork management. DNA Repair (Amst.) 6 (2007) 936-944
102. O'Driscoll M., Gennery A.R., Seidel J., Concannon P., and Jeggo P.A. An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amst.) 3 (2004) 1227-1235
103. Goodship J., Gill H., Carter J., Jackson A., Splitt M., and Wright M. Autozygosity mapping of a seckel syndrome locus to chromosome 3q22. 1-q24. Am. J. Hum. Genet. 67 (2000) 498-503
104. O'Driscoll M., Ruiz-Perez V.L., Woods C.G., Jeggo P.A., and Goodship J.A. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33 (2003) 497-501
105. Hayani A., Suarez C.R., Molnar Z., LeBeau M., and Godwin J. Acute myeloid leukaemia in a patient with Seckel syndrome. J. Med. Genet. 31 (1994) 148-149
106. Wang P., Spielberger R.T., Thangavelu M., Zhao N., Davis E.M., Iannantuoni K., Larson R.A., and Le Beau M.M. dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53. Genes Chromosomes Cancer 20 (1997) 282-291
107. Paulsen R.D., and Cimprich K.A. The ATR pathway: fine-tuning the fork. DNA Repair (Amst.) 6 (2007) 953-966
108. Shechter D., Costanzo V., and Gautier J. Regulation of DNA replication by ATR: signaling in response to DNA intermediates. DNA Repair (Amst.) 3 (2004) 901-908
109. Zhao H., and Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 21 (2001) 4129-4139
110. Busino L., Donzelli M., Chiesa M., Guardavaccaro D., Ganoth D., Dorrello N.V., Hershko A., Pagano M., and Draetta G.F. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 426 (2003) 87-91
111. Jin J., Shirogane T., Xu L., Nalepa G., Qin J., Elledge S.J., and Harper J.W. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17 (2003) 3062-3074
112. Bartek J., Lukas C., and Lukas J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell. Biol. 5 (2004) 792-804
113. Andreassen P.R., D'Andrea A.D., and Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18 (2004) 1958-1963
114. Ho G.P., Margossian S., Taniguchi T., and D'Andrea A.D. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol. Cell. Biol. 26 (2006) 7005-7015
115. Montes de Oca R., Andreassen P.R., Margossian S.P., Gregory R.C., Taniguchi T., Wang X., Houghtaling S., Grompe M., and D'Andrea A.D. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood 105 (2005) 1003-1009
116. Pace P., Johnson M., Tan W.M., Mosedale G., Sng C., Hoatlin M., de Winter J., Joenje H., Gergely F., and Patel K.J. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21 (2002) 3414-3423
117. Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald III E.R., Hurov K.E., Luo J., Ballif B.A., Gygi S.P., Hofmann K., D'Andrea A.D., and Elledge S.J. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129 (2007) 289-301
118. Qiao F., Mi J., Wilson J.B., Zhi G., Bucheimer N.R., Jones N.J., and Kupfer G.M. Phosphorylation of fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway. J. Biol. Chem. 279 (2004) 46035-46045
119. Wilson J.B., Yamamoto K., Marriott A.S., Hussain S., Sung P., Hoatlin M.E., Mathew C.G., Takata M., Thompson L.H., Kupfer G.M., and Jones N.J. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Oncogene 27 (2008) 3641-3652
120. Yu X., Chini C.C., He M., Mer G., and Chen J. The BRCT domain is a phospho-protein binding domain. Science 302 (2003) 639-642
121. Mi J., Qiao F., Wilson J.B., High A.A., Schroeder M.J., Stukenberg P.T., Moss A., Shabanowitz J., Hunt D.F., Jones N.J., and Kupfer G.M. FANCG is phosphorylated at serines 383 and 387 during mitosis. Mol. Cell. Biol. 24 (2004) 8576-8585
122. Howlett N.G., Taniguchi T., Durkin S.G., D'Andrea A.D., and Glover T.W. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet. 14 (2005) 693-701
123. Lomonosov M., Anand S., Sangrithi M., Davies R., and Venkitaraman A.R. Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev. 17 (2003) 3017-3022
124. Sobeck A., Stone S., Costanzo V., de Graaf B., Reuter T., de Winter J., Wallisch M., Akkari Y., Olson S., Wang W., Joenje H., Christian J.L., Lupardus P.J., Cimprich K.A., Gautier J., and Hoatlin M.E. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. Mol. Cell. Biol. 26 (2006) 425-437
125. Zou L., and Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300 (2003) 1542-1548
126. Collis S.J., Barber L.J., Clark A.J., Martin J.S., Ward J.D., and Boulton S.J. HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. Nat. Cell Biol. 9 (2007) 391-401
127. Papadopoulo D., Porfirio B., and Moustacchi E. Mutagenic response of Fanconi's anemia cells from a defined complementation group after treatment with photoactivated bifunctional psoralens. Cancer Res. 50 (1990) 3289-3294
128. Papadopoulo D., Guillouf C., Mohrenweiser H., and Moustacchi E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 8383-8387
129. Mirchandani K.D., McCaffrey R.M., and D'Andrea A.D. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA Repair (Amst.) 7 (2008) 902-911
130. Nojima K., Hochegger H., Saberi A., Fukushima T., Kikuchi K., Yoshimura M., Orelli B.J., Bishop D.K., Hirano S., Ohzeki M., Ishiai M., Yamamoto K., Takata M., Arakawa H., Buerstedde J.M., Yamazoe M., Kawamoto T., Araki K., Takahashi J.A., Hashimoto N., Takeda S., and Sonoda E. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res. 65 (2005) 11704-11711
131. Lehmann A.R. Translesion synthesis in mammalian cells. Exp. Cell Res. 312 (2006) 2673-2676
132. Ulrich H.D. The RAD6 pathway: control of DNA damage bypass and mutagenesis by ubiquitin and SUMO. Chembiochem 6 (2005) 1735-1743
133. Nelson J.R., Lawrence C.W., and Hinkle D.C. Deoxycytidyl transferase activity of yeast REV1 protein. Nature 382 (1996) 729-731
134. Garg P., Stith C.M., Majka J., and Burgers P.M. Proliferating cell nuclear antigen promotes translesion synthesis by DNA polymerase zeta. J. Biol. Chem. 280 (2005) 23446-23450
135. Lawrence C.W. Cellular functions of DNA polymerase zeta and Rev1 protein. Adv. Protein Chem. 69 (2004) 167-203
136. Johnson R.E., Kondratick C.M., Prakash S., and Prakash L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 285 (1999) 263-265
137. Masutani C., Kusumoto R., Iwai S., and Hanaoka F. Mechanisms of accurate translesion synthesis by human DNA polymerase eta. EMBO J. 19 (2000) 3100-3109
138. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., Araki M., Iwai S., Takio K., and Hanaoka F. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399 (1999) 700-704
139. Lawrence C.W. Cellular roles of DNA polymerase zeta and Rev1 protein. DNA Repair (Amst.) 1 (2002) 425-435
140. Hoege C., Pfander B., Moldovan G.L., Pyrowolakis G., and Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419 (2002) 135-141
141. Friedberg E.C., Lehmann A.R., and Fuchs R.P. Trading places: how do DNA polymerases switch during translesion DNA synthesis?. Mol. Cell 18 (2005) 499-505
142. Kannouche P.L., Wing J., and Lehmann A.R. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell 14 (2004) 491-500
143. Gary R., Ludwig D.L., Cornelius H.L., MacInnes M.A., and Park M.S. The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21. J. Biol. Chem. 272 (1997) 24522-24529
144. Guo C., Sonoda E., Tang T.S., Parker J.L., Bielen A.B., Takeda S., Ulrich H.D., and Friedberg E.C. REV1 protein interacts with PCNA: significance of the REV1 BRCT domain in vitro and in vivo. Mol. Cell 23 (2006) 265-271
145. Guo C., Tang T.S., Bienko M., Parker J.L., Bielen A.B., Sonoda E., Takeda S., Ulrich H.D., Dikic I., and Friedberg E.C. Ubiquitin-binding motifs in REV1 protein are required for its role in the tolerance of DNA damage. Mol. Cell. Biol. 26 (2006) 8892-8900
146. Kleczkowska H.E., Marra G., Lettieri T., and Jiricny J. hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci. Genes Dev. 15 (2001) 724-736
147. Moldovan G.L., Pfander B., and Jentsch S. PCNA, the maestro of the replication fork. Cell 129 (2007) 665-679
148. Ulrich H.D. How to activate a damage-tolerant polymerase: consequences of PCNA modifications by ubiquitin and SUMO. Cell Cycle 3 (2004) 15-18
149. Adachi D., Oda T., Yagasaki H., Nakasato K., Taniguchi T., D'Andrea A.D., Asano S., and Yamashita T. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants. Hum. Mol. Genet. 11 (2002) 3125-3134
150. Chen J.J., Silver D., Cantor S., Livingston D.M., and Scully R. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res. 59 (1999) 1752s-1756s
151. Hussain S., Wilson J.B., Medhurst A.L., Hejna J., Witt E., Ananth S., Davies A., Masson J.Y., Moses R., West S.C., De Winter J.P., Ashworth A., Jones N.J., and Mathew C.G. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 13 (2004) 1241-1248
152. Huang T.T., Nijman S.M., Mirchandani K.D., Galardy P.J., Cohn M.A., Haas W., Gygi S.P., Ploegh H.L., Bernards R., and D'Andrea A.D. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat. Cell Biol. 8 (2006) 339-347
153. Nijman S.M., Huang T.T., Dirac A.M., Brummelkamp T.R., Kerkhoven R.M., D'Andrea A.D., and Bernards R. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17 (2005) 331-339
154. Simpson L.J., and Sale J.E. Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J. 22 (2003) 1654-1664
155. Sonoda E., Okada T., Zhao G.Y., Tateishi S., Araki K., Yamaizumi M., Yagi T., Verkaik N.S., van Gent D.C., Takata M., and Takeda S. Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. EMBO J. 22 (2003) 3188-3197
156. Bienko M., Green C.M., Crosetto N., Rudolf F., Zapart G., Coull B., Kannouche P., Wider G., Peter M., Lehmann A.R., Hofmann K., and Dikic I. Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science 310 (2005) 1821-1824
157. Wood A., Garg P., and Burgers P.M. A ubiquitin-binding motif in the translesion DNA polymerase Rev1 mediates its essential functional interaction with ubiquitinated proliferating cell nuclear antigen in response to DNA damage. J. Biol. Chem. 282 (2007) 20256-20263
158. Koken M.H., Smit E.M., Jaspers-Dekker I., Oostra B.A., Hagemeijer A., Bootsma D., and Hoeijmakers J.H. Localization of two human homologs, HHR6A and HHR6B, of the yeast DNA repair gene RAD6 to chromosomes Xq24-q25 and 5q23-q31. Genomics 12 (1992) 447-453
159. Zhang J., Zhao D., Wang H., Lin C.J., and Fei P. FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways. Cell Cycle 7 (2008) 407-413
160. Matsushita N., Kitao H., Ishiai M., Nagashima N., Hirano S., Okawa K., Ohta T., Yu D.S., McHugh P.J., Hickson I.D., Venkitaraman A.R., Kurumizaka H., and Takata M. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19 (2005) 841-847
161. Edmunds C.E., Simpson L.J., and Sale J.E. PCNA ubiquitination and REV1 define temporally distinct mechanisms for controlling translesion synthesis in the avian cell line DT40. Mol. Cell 30 (2008) 519-529
162. Nagaraju G., and Scully R. Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. DNA Repair (Amst.) 6 (2007) 1018-1031
163. Kannouche P., Fernandez de Henestrosa A.R., Coull B., Vidal A.E., Gray C., Zicha D., Woodgate R., and Lehmann A.R. Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells. EMBO J. 21 (2002) 6246-6256
164. Oestergaard V.H., Langevin F., Kuiken H.J., Pace P., Niedzwiedz W., Simpson L.J., Ohzeki M., Takata M., Sale J.E., and Patel K.J. Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol. Cell 28 (2007) 798-809
165. Cohn M.A., Kowal P., Yang K., Haas W., Huang T.T., Gygi S.P., and D'Andrea A.D. A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol. Cell 28 (2007) 786-797
166. Ren B., Cam H., Takahashi Y., Volkert T., Terragni J., Young R.A., and Dynlacht B.D. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16 (2002) 245-256
167. Machida Y.J., Machida Y., Chen Y., Gurtan A.M., Kupfer G.M., D'Andrea A.D., and Dutta A. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23 (2006) 589-596
168. Alpi A., Langevin F., Mosedale G., Machida Y.J., Dutta A., and Patel K.J. UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination. Mol. Cell. Biol. 27 (2007) 8421-8430
169. Haglund K., and Stenmark H. Working out coupled monoubiquitination. Nat. Cell Biol. 8 (2006) 1218-1219
170. Hicke L., Schubert H.L., and Hill C.P. Ubiquitin-binding domains. Nat. Rev. Mol. Cell. Biol. 6 (2005) 610-621
171. Fernandez-Capetillo O., Lee A., Nussenzweig M., and Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 3 (2004) 959-967
172. Stucki M., and Jackson S.P. gammaH2AX and MDC1: anchoring the DNA-damage-response machinery to broken chromosomes. DNA Repair (Amst.) 5 (2006) 534-543
173. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J., Redon C., Pilch D.R., Olaru A., Eckhaus M., Camerini-Otero R.D., Tessarollo L., Livak F., Manova K., Bonner W.M., Nussenzweig M.C., and Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science 296 (2002) 922-927
174. Bogliolo M., Lyakhovich A., Callen E., Castella M., Cappelli E., Ramirez M.J., Creus A., Marcos R., Kalb R., Neveling K., Schindler D., and Surralles J. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J. 26 (2007) 1340-1351
175. Ward I.M., and Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276 (2001) 47759-47762
176. Durkin S.G., Arlt M.F., Howlett N.G., and Glover T.W. Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene 25 (2006) 4381-4388
177. Wang X., Kennedy R.D., Ray K., Stuckert P., Ellenberger T., and D'Andrea A.D. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 27 (2007) 3098-3108
178. Guervilly J.H., Mace-Aime G., and Rosselli F. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia. Hum. Mol. Genet. 17 (2008) 679-689
179. Durkin S.G., and Glover T.W. Chromosome fragile sites. Annu. Rev. Genet. 41 (2007) 169-192
180. Downs J.A., Nussenzweig M.C., and Nussenzweig A. Chromatin dynamics and the preservation of genetic information. Nature 447 (2007) 951-958
181. Vidanes G.M., Bonilla C.Y., and Toczyski D.P. Complicated tails: histone modifications and the DNA damage response. Cell 121 (2005) 973-976
182. Hejna J., Holtorf M., Hines J., Mathewson L., Hemphill A., Al-Dhalimy M., Olson S.B., and Moses R.E. Tip60 is required for DNA interstrand cross-link repair in the Fanconi anemia pathway. J. Biol. Chem. 283 (2008) 9844-9851
183. Sun Y., Jiang X., Chen S., Fernandes N., and Price B.D. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13182-13187
184. Tang Y., Luo J., Zhang W., and Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 24 (2006) 827-839
185. Bhoumik A., Singha N., O'Connell M.J., and Ronai Z.A. Regulation of TIP60 by ATF2 modulates ATM activation. J. Biol. Chem. 283 (2008) 17605-17614
186. Otsuki T., Furukawa Y., Ikeda K., Endo H., Yamashita T., Shinohara A., Iwamatsu A., Ozawa K., and Liu J.M. Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Hum. Mol. Genet. 10 (2001) 2651-2660
187. Akkari Y.M., Bateman R.L., Reifsteck C.A., Olson S.B., and Grompe M. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol. Cell. Biol. 20 (2000) 8283-8289
188. Rothfuss A., and Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 24 (2004) 123-134